Access cutting-edge liver cancer treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This research study is studying an immunotherapy drug (pembrolizumab or KEYTRUDA) as a possible treatment for pediatric hepatocellular carcinoma or hepatocellular neoplasm not otherwise specified (HCN NOS).
Sponsor: Allison O'Neill, MD
Check if you qualify for this liver cancer clinical trial in Cincinnati, OH
If you're searching for liver cancer treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.